Aridis Pharmaceuticals, Inc.·4

Jul 15, 8:06 AM ET

Windham-Bannister Susan Richards 4

4 · Aridis Pharmaceuticals, Inc. · Filed Jul 15, 2019

Insider Transaction Report

Form 4
Period: 2019-07-12
Transactions
  • Award

    Stock Options

    2019-07-12+35,00035,000 total
    Exercise: $10.01Exp: 2029-07-12Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]972 of the stock options vested upon date of grant and the remaining stock options vest in equal installments over 35 months beginning on July 12, 2019.

Documents

1 file
  • 4
    a4.xmlPrimary

    4